“失眠第一方”半夏秫米汤治疗失眠的作用机制研究进展

Research progress on the mechanism of Banxia shumi decoction, the first prescription for insomnia, in treating insomnia

ES评分 0

DOI 10.12208/j.ircm.20240043
刊名
International Research in Chinese Medicine
年,卷(期) 2024, 4(3)
作者
作者单位

1 天津中医药大学第二附属医院脑病针灸中心 天津 ;
2 天津中医药大学中医药研究院组分中药国家重点实验室 天津 ;

摘要
随着生活节奏加快,失眠人数与日俱增。长期失眠会导致疲倦、情绪烦躁、记忆力减退等,甚至诱发各种疾病。目前,临床上常采用苯二氮䓬类、非苯二氮䓬类、褪黑素受体激动剂等治疗失眠,虽然其疗效显著、起效快,但长期使用易产生依赖性、成瘾性,在一定程度上限制了失眠的治疗。被誉为“失眠第一方”的半夏秫米汤治疗失眠具有历史悠久、疗效显著、副作用小等特点。鉴于此,本文将概述半夏秫米汤治疗失眠的作用机制研究进展,旨在为其治疗失眠提供参考。
Abstract
As the pace of life accelerates, the number of people suffering from insomnia is increasing day by day. Long term insomnia can lead to fatigue, emotional distress, memory loss, and even trigger various diseases. At present, benzodiazepines, non benzodiazepines, and melatonin receptor agonists are commonly used in clinical practice to treat insomnia. Although they have significant therapeutic effects and fast onset, long-term use can easily lead to dependence and addiction, which to some extent limits the treatment of insomnia. Banxia shumi decoction, known as the “first treatment for insomnia”, has a long history, significant therapeutic effects, and minimal side effects in treating insomnia. In view of this, this article will summarize the research progress on the mechanism of Banxia shumi decoction in treating insomnia, aiming to provide reference for its treatment of insomnia.
关键词
半夏秫米汤;失眠;神经递质;HPA轴;炎症因子
KeyWord
Banxia shumi decoction; Insomnia; Neurotransmitters; HPA axis; Inflammatory factors
基金项目
页码 6-9
  • 参考文献
  • 相关文献
  • 引用本文

宋宛珊,张怡博,李非凡,王静,黄熙,朱金墙*. “失眠第一方”半夏秫米汤治疗失眠的作用机制研究进展 [J]. 国际中医药研究. 2024; 4; (3). 6 - 9.

  • 文献评论

相关学者

相关机构